Low-dose cyclosporin A in severe psoriasis. A double-blind study
β Scribed by TH. VAN JOOST; J.D. BOS; F. HEULE; M.M.H.M. MEINARDI
- Book ID
- 108660028
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 455 KB
- Volume
- 118
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This study compared the efficacy, safety and optimal dose of two formulations of cyclosporin, Sandimmun and Neoral, in patients with severe, chronic plaque-type psoriasis. Patients were randomized on a 1:1 basis to 24 weeks of treatment with Neoral (n = 152) or Sandimmun (n = 157). The starting dose
We previously showed in a double-blind, placebo-controlled study that cyclosporin at a dose of 2.5 mg/kg per day is an effective treatment for palmoplantar pustulosis (PPP). In the present randomized, double-blind, placebo-controlled multicentre study we treated 58 PPP patients with placebo or cyclo
## Background: Histamine-releasing activity (hra) is detectable in up to 50% of patients with chronic ordinary urticaria. ## Objectives: To determine the effect of cyclosporin on clinical features and hra in patients with chronic urticaria. ## Methods: Thirty patients with severe unremitting di